CSGALNACT2 restricts ovarian cancer migration and invasion by modulating MAPK/ERK pathway through DUSP1.
Ma M, Wang C, Wu M, Gu S, Yang J, Zhang Y, Cheng S, Xu S, Zhang M, Wu Y, Zhao Y, Tian X, Voon DC, Takahashi C, Sheng J, Wang Y.
Ma M, et al.
Cell Oncol (Dordr). 2023 Dec 12. doi: 10.1007/s13402-023-00903-9. Online ahead of print.
Cell Oncol (Dordr). 2023.
PMID: 38082211